Please use this identifier to cite or link to this item:
Title: PTEN Loss Is Associated with Worse Outcome in HER2-Amplified Breast Cancer Patients but Is Not Associated with Trastuzumab Resistance.
Issue Date: 1-May-2015
Citation: Clin. Cancer Res..2015 May;(21)9:2065-74
Abstract: To investigate the clinical relevance of PTEN in HER2-amplified and HER2-nonamplified disease.
PMID: 25649019
Rights: openAccess
ISSN: 1078-0432
Appears in Collections:Fundaciones e Institutos de Investigación > IIS H. U. Clínico San Carlos > Artículos

Files in This Item:
File Description SizeFormat 
PMC4417419.pdf2.47 MBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.